1. Home
  2. Analysis
  3. Gabapentin
  4. Reticulocyte-count-increased

Gabapentin and Reticulocyte count increased - a phase IV clinical study of FDA data

Summary:

Reticulocyte count increased is reported as a side effect among people who take Gabapentin (gabapentin), especially for people who are female, 50-59 old, also take Ondansetron, and have Anaemia.

The phase IV clinical study analyzes which people have Reticulocyte count increased when taking Gabapentin. It is created by eHealthMe based on reports of 313,421 people who have side effects when taking Gabapentin from the FDA, and is updated regularly.

What is Gabapentin?

Gabapentin has active ingredients of gabapentin. It is often used in peripheral neuropathy. eHealthMe is studying from 322,987 Gabapentin users. Check the latest studies of Gabapentin.

What is Reticulocyte count increased?

Reticulocyte count increased is found to be associated with 164 drugs and 318 conditions by eHealthMe. Check the latest studies of Reticulocyte count increased.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 20, 2026

313,421 people reported to have side effects when taking Gabapentin.
Among them, 28 people (0.01%) have Reticulocyte count increased.

Could Gabapentin cause Reticulocyte count increased?

Among these 28 people:

What is the gender of people who have Reticulocyte count increased when taking Gabapentin? *

  • female: 96.15 %
  • male: 3.85 %

What is the age of people who have Reticulocyte count increased when taking Gabapentin? *

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 15 %
  • 30-39: 0.0 %
  • 40-49: 5 %
  • 50-59: 50 %
  • 60+: 30 %

What are other drugs people take besides Gabapentin? *

  1. Ondansetron: 12 people, 42.86%
  2. Oxycontin: 11 people, 39.29%
  3. Hydrocortisone: 11 people, 39.29%
  4. Ambien: 9 people, 32.14%
  5. Aranesp: 9 people, 32.14%
  6. Ibuprofen: 9 people, 32.14%
  7. Zosyn: 8 people, 28.57%
  8. Neurontin: 8 people, 28.57%
  9. Nasonex: 8 people, 28.57%
  10. Zometa: 8 people, 28.57%

What are other side effects people have besides Reticulocyte count increased? *

  1. Red Blood Cell Count Decreased: 20 people, 71.43%
  2. Fever: 18 people, 64.29%
  3. Haematocrit Decreased: 18 people, 64.29%
  4. White Blood Cell Count Decreased: 14 people, 50.00%
  5. Anaemia (lack of blood): 14 people, 50.00%
  6. Dehydration (dryness resulting from the removal of water): 13 people, 46.43%
  7. Neuropathy Peripheral (surface nerve damage): 13 people, 46.43%
  8. Metastases To Bone (cancer spreads to bone): 13 people, 46.43%
  9. Intervertebral Disc Protrusion (spinal disc protrusion): 12 people, 42.86%
  10. C-Reactive Protein Increased: 12 people, 42.86%

What are the existing conditions these people have? *

  1. Musculoskeletal Pain (pain affects the bones, muscles, ligaments, tendons, and nerves): 8 people, 28.57%
  2. Anaemia (lack of blood): 8 people, 28.57%
  3. Multiple Myeloma (cancer of the plasma cells): 7 people, 25.00%
  4. Breast Cancer Metastatic: 5 people, 17.86%
  5. Bone Disorder: 5 people, 17.86%
  6. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 3 people, 10.71%
  7. Psoriasis (immune-mediated disease that affects the skin): 3 people, 10.71%
  8. Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 3 people, 10.71%
  9. Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 3.57%
  10. Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 1 person, 3.57%

* Approximation only. Some reports may have incomplete information.

Do you take Gabapentin and have Reticulocyte count increased?

- Check whether Reticulocyte count increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gabapentin:

Reticulocyte count increased treatments and more:

How severe was Reticulocyte count increased and when was it recovered:

Expand to all the drugs that have ingredients of gabapentin:

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Gabapentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Reticulocyte count increased:

Browse all the conditions that are associated with Reticulocyte count increased:

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on gabapentin (the active ingredients of Gabapentin) and Gabapentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.